Trial · NCT07546721
Exercise Training for People With Advanced Multiple Sclerosis
NCT07546721, Not applicable, Not yet recruiting, University of Ottawa
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Exercise Training for People With Advanced Multiple Sclerosis. Trials, record NCT07546721. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07546721
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Exercise Training for People With Advanced Multiple Sclerosis
- NCT number
- NCT07546721
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 12 participants, estimated
- Lead sponsor
- University of Ottawa
- Conditions
- Multiple Sclerosis
- Interventions
- Aerobic Exercise Training
- First posted
- 2026-04-23
- Last updated
- 2026-04-23
Source ClinicalTrials.gov
Registered outcomes31
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Feasibility - Recruitment duration | Ongoing during the study recruitment period. | Total number of days taken to recruit participants. |
| Primary | Feasibility - Recruitment methods | Ongoing during the study recruitment period. | All methods (types/sources) used to recruit participants. |
| Primary | Feasibility - Recruitment screening time | Ongoing during the study recruitment period. | Time spent screening each participant (minutes). |
| Primary | Feasibility - Recruitment eligibility rate | Ongoing during the study recruitment period. | Percentage of screened individuals who were eligible for study participation. |
| Primary | Feasibility - Recruitment exclusion reasons | Ongoing during the study recruitment period. | Frequency of exclusion criteria recorded during eligibility screening. |
| Primary | Feasibility - Adherence | Ongoing during the 12-week intervention. | Total number of sessions attended out of a possible 24. |
| Primary | Feasibility - Compliance frequency | Ongoing during the 12-week intervention. | Extent to which each participant followed the prescribed exercise protocol in terms of frequency (sessions/week). |
| Primary | Feasibility - Compliance duration | Ongoing during the 12-week intervention. | Extent to which each participant followed the prescribed exercise protocol in terms of duration (minutes/session). |
| Primary | Feasibility - Compliance intensity | Ongoing during the 12-week intervention. | Extent to which each participant followed the prescribed exercise protocol in terms of intensity. |
| Primary | Feasibility - Attrition frequency | Over the course of the 24-week study period. | Total number of participants who dropped out of the study before completion. |
1 to 10 of 31Source ClinicalTrials.gov
See all 31 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Paced Visual Serial Addition Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Symbol Coding | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07546721
GET https://conductscience.org/api/trials/v1/NCT07546721/registered?page=2